Loading...
Loading...
By Sofía Garduño - Fri, 11/21/2025 - 12:32
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
Featured content
Partnership Content
https://mexicobusiness.news/tag/karla-alcazar
More Health
By Sofía Garduño - Fri, 11/21/2025 - 11:55
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
By Sofía Garduño - Wed, 09/10/2025 - 11:10
Collaboration between government, industry, academia, and society is key to driving healthcare innovation and improving access in Mexico.
By Sofía Garduño - Wed, 07/17/2024 - 17:41
There is an urgent need for enhanced prevention efforts to address the rising prevalence of hypertension, diabetes, and obesity.
By Sofía Garduño - Mon, 07/01/2024 - 14:13
Collaboration is required to address the health crisis caused by the growing rates of diabetes in Mexico, says Eli Lilly’s Karla Alcazar.
